Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adverse prognostic impact of vascular endothelial growth factor gene polymorphisms in patients with diffuse large B-cell lymphoma.

Leukemia & lymphoma - 1 Nov 2017

Yoon Kyong-Ah, Kim Min Kyeong, Eom Hyeon-Seok, Lee Hyewon, Park Weon Seo, Sohn Ji Yeon, Kim Man Jin, Kong Sun-Young

Abstract excerpt

Vascular endothelial growth factor (VEGF) plays an important role in angiogenesis and progression of cancer and its expression was associated with gene polymorphisms. Since the impact of polymorphisms of the VEGF on non-Hodgkin lymphoma prognosis has not been fully elucidated, we investigated 149 diffuse large B-cell lymphoma (DLBCL) patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclophosphamide
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Doxorubicin

Share to Lymphoma, Large B-Cell, Diffuse

Share to Prednisone

Share to Rituximab

Share to Vascular Endothelial Growth Factor A

Share to Vincristine

Source

Identifiers

PMID: 28326867
DOI: 10.1080/10428194.2017.1300893

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adverse prognostic impact of vascular endothelial growth factor gene polymorphisms in patients with diffuse large B-cell lymphoma.PMID 28326867Read ↗

VEGFA and VEGFR2 genetic polymorphisms and survival in patients with diffuse large B cell lymphoma.Semantic proximity Read ↗

Angiogenesis' related genetic variants alter clinical features and prognosis of diffuse large B-cell lymphoma patients.Semantic proximity Read ↗

Association of single nucleotide variants in VEGFA and KDR with the risk and angiogenic features of diffuse large B-cell lymphoma.Semantic proximity Read ↗

VEGFR2 and VEGFA polymorphisms are not associated with an inferior prognosis in Caucasian patients with aggressive B-cell lymphoma.Semantic proximity Read ↗

Association of VEGF genetic polymorphisms with the clinical characteristics of non-Hodgkin's lymphoma.Semantic proximity Read ↗

Prognostic values of various clinical factors and genetic subtypes for diffuse large B-cell lymphoma patients: a retrospective analysis of 227 cases.Semantic proximity Read ↗

Angiogenesis-related gene signature for prognostic prediction and immune microenvironment characterization in diffuse large B-cell lymphomaSemantic proximity Read ↗

The Effect of FcγRIIIA Gene Polymorphism on the Treatment of Diffuse Large B-cell Non-Hodgkin Lymphoma: A Multicenter Prospective Observational Study.Semantic proximity Read ↗

Polymorphism in IKZF1 gene affects clinical outcome in diffuse large B-cell lymphoma.Semantic proximity Read ↗

Prognostic and predictive role of vascular endothelial growth factor polymorphisms in breast cancer.Semantic proximity Read ↗

Prognostic impact of TP53 mutations in diffuse large B-cell lymphoma.Semantic proximity Read ↗

Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.